
Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …

The UK should have one universal health technology assessor which should seek to tighten up rules on whether new drugs …

Bristol-Myers Squibb has elected Thomas Lynch to its board to serve as a member on its Science and Technology Committee …
The year 2013 brought a new series of challenges for pharma. As the dust settled following the bulk of major …

Chiesi has had the book thrown at it by the PMCPA and faces the shame of a public reprimand – …

The Department of Health has this week released an Apple and Android game app designed to get the UK public …

Sanofi has been cleared of the most serious breach of the ABPI Code of Practice – despite appearing to offer …

Comms giant McCann Health has hired Susan Duffy to be president of its New York-based McCann Regan Campbell Ward (RCW). …

AstraZeneca has pledged to donate its Devon-based Environmental Laboratory to Plymouth University, after announcing the site’s closure in October. The …

The healthcare division of comms agency giant Ketchum is weathering a tough month following job cuts and a key resignation. …
The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …

GlaxoSmithKline has made good on a pledge to invest in UK-based production, with £200 million ($328m) earmarked for plant upgrades …

The FDA is to conduct a speedy investigation into Sanofi’s twice-daily oral candidate for Gaucher disease, which means that Cerdelga …

The ABPI has appointed Raj Tugnet as its new NHS partnership manager to lead ABPI activities on academic health science …

Novo Nordisk is facing an investigation from Denmark’s police over delaying the release of negative information it received from the …

UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …

A NASDAQ disciplinary committee has found Medivir guilty of breaching its rules after data from a trial was posted on …

AbbVie’s investigational hepatitis C pill cured 96% of difficult-to-treat patients in a late-stage clinical trial and looks set to muscle …

Merck Sharp & Dohme has confirmed that Mike Nally will succeed Deepak Khanna as managing director for MSD in the …

The boss of a French firm at the centre of a global health scare over faulty breast implants has been …